Commentary
Video
Standard Treatments for NRG1 Fusion+ NSCLC
Author(s):
D. Ross Camidge, MD, PhD, of University of Colorado Health Lung Cancer Clinic – Anschutz Medical Campus, discusses standard treatments for patients with non–small cell lung cancer who harbor NRG1 fusions.
EP: 1.Prevalence of NRG1 Fusions in Lung Cancer
EP: 2.Differences Between DNA and RNA Testing for NRG1
Now Viewing
EP: 3.Standard Treatments for NRG1 Fusion+ NSCLC
EP: 4.Ongoing Research Efforts Targeting NRG1 in Lung Cancer
EP: 5.Efficacy With NRG1-Directed Agents in NSCLC
EP: 6.Prognosis, Rarity of NRG1+ Pancreatic Cancer
EP: 7.Choosing RNA Over DNA Testing for NRG1 Fusions in Pancreatic Cancer
EP: 8.Standard Treatment Regimens for NRG1+ Pancreatic Cancer
EP: 9.Poised Potential With Zenocutuzumab in NRG1+ Pancreatic Cancer
Related Videos
Related Content
